Fluorinated betulinic acid derivatives and evaluation of their anti-HIV activity

Bioorg Med Chem Lett. 2016 Jan 1;26(1):68-71. doi: 10.1016/j.bmcl.2015.11.029. Epub 2015 Nov 11.

Abstract

Several fluorinated derivatives of the anti-HIV maturation agent bevirimat (1) were synthesized and evaluated for anti-HIV replication activity. The modified positions were the C-2, C-3, C-28, and C-30 positions, either directly on the betulinic acid (2) skeleton or in the attached side chains. Compound 18, which has a trifluoromethyl group added to C-30 of its isopropenyl group, exhibited similar potency to 1 against HIV-1NL4-3. In total, our current studies support our prior conclusion that C-30 allylic modification is unlikely to be a pharmacophore for anti-HIV activity, but could be a meaningful route to manipulate other properties of 2-related compounds.

Keywords: Anti-HIV activity; Bevirimat; Fluorinated betulinic acid derivatives.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Anti-HIV Agents / chemical synthesis
  • Anti-HIV Agents / chemistry
  • Anti-HIV Agents / pharmacology*
  • Betulinic Acid
  • Dose-Response Relationship, Drug
  • HIV / drug effects*
  • Halogenation
  • Microbial Sensitivity Tests
  • Molecular Conformation
  • Pentacyclic Triterpenes
  • Structure-Activity Relationship
  • Triterpenes / chemical synthesis
  • Triterpenes / chemistry
  • Triterpenes / pharmacology*
  • Virus Replication / drug effects

Substances

  • Anti-HIV Agents
  • Pentacyclic Triterpenes
  • Triterpenes
  • Betulinic Acid